Protalix Biotherapeutics Inc (PLX)
R&D to Revenue
21.87%
Quarterly · Period ending:
PLX R&D to Revenue
Latest reported21.87%period ending
Latest reported21.87%period ending
PLX Quarterly R&D/Revenue (0.00% → 21.87%)
Latest values, visible window
High-resolution chart · PNG
PLX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |